Quantitative measurement of hepatitis C virus core antigen is affected by the presence of cryoglobulins

Clinical and Experimental Immunology

Volumn 146, Issue 2, 2006, Pages 211-217

  Pham, B N ^a   Martinot Peignoux, M ^a   Ripault, M P ^a   Boyer, N ^a   Levy, V ^b   Marcellin, P ^a  

^a BEAUJON HOSPITAL   (France)

^b SAINT LOUIS HOSPITAL   (France)

Author keywords

Cryoglobulinaemia; Cryoglobulins; HCV core antigen; HCV RNA; Hepatitis C

Indexed keywords

CRYOGLOBULIN; HEPATITIS C VIRUS CORE ANTIGEN; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS RNA;

ADULT; ARTICLE; BLOOD SAMPLING; CRYOGLOBULINEMIA; CRYOPRECIPITATE; FEMALE; HEPATITIS C VIRUS; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; QUALITATIVE ANALYSIS;

BLOOD SPECIMEN COLLECTION; CRYOGLOBULINEMIA; CRYOGLOBULINS; FEMALE; HEPACIVIRUS; HEPATITIS C ANTIGENS; HEPATITIS C, CHRONIC; HUMANS; MALE; PROSPECTIVE STUDIES; RNA, VIRAL; VIRAL CORE PROTEINS;

EID: 33750054670     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2006.03196.x     Document Type: Article

References (26)

1. Brouet J-C, Clauvel J-P, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins: a report of 86 cases. Am J Med 1974; 57:775-88.
2. Ferri C, Zignego AL, Pileri SA. Cryoglobulins. J Clin Path 2005; 55:4-13.
3. Pawlotsky JM, Ben Yahia M, Andre C et al. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Hepatology 1994; 19:841-8.
4. Cacoub P, Lunel-Fabiani F, Musset L et al. Mixed cryoglobulinaemia and hepatitis C virus. Am J Med 1994; 96:124-32.
5. Wong VS, Egner W, Elsey T, Brown D, Alexander GJ. Incidence, character and clinical relevance of mixed cryoglobulinaemia in patients with chronic hepatitis C virus infection. Clin Exp Immunol 1996; 104:25-31.
6. Horcajada JP, Garcia-Bengoechea M, Cilla G, Etxaniz P, Cuadrado E, Arenas JI. Mixed cryoglobulinaemia in patients with chronic hepatitis C infection: prevalence, significance and relationship with different viral genotypes. Ann Med 1999; 31:352-8.
7. Kayali Z, Buckwold VE, Zimmerman B, Schmidt WN. Hepatitis C, cryoglobulinaemia, and cirrhosis: a meta-analysis. Hepatology 2002; 36:978-85.
8. Ferri C, Sebastiani M, Giuggioli D et al. Mixed cryoglobulinaemia: Demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum 2004; 33:355-74.
9. Misiani R, Bellavita P, Fenili D et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinaemia. Ann Int Med 1992; 117:573-7.
10. Mazzaro C, Tulissi P, Moretti M et al. Clinical and virological findings in mixed cryoglobulinaemia. J Intern Med 1995; 238:153-60.
11. Aoyagi K, Ohue C, Iida K et al. Development of a simple and highly enzyme immunoassay for hepatitis C virus core antigen. J Clin Microbiol 1999; 37:1802-8.
12. Zanetti AR, Romano L, Brunetto M, Colombo M, Bellati G, Tackney C. Total HCV core antigen assay: a new marker of hepatitis C viremia for monitoring the progress of therapy. J Med Virol 2003; 70:27-30.
13. Rebucci C, Cerino A, Cividini A, Timo L, Furione M, Mondelli M. Monitoring response to antiviral therapy for patients with chronic hepatitis C virus infection by a core-antigen assay. J Clin Microbiol 2003; 41:3881-4.
14. Maynard M, Pradat P, Berthillon P et al. Clinical relevance of total HCV core antigen testing for hepatitis C monitoring and for predicting patients'response to therapy. J Virol Hepatitis 2003; 10:318-23.
15. Christodoulou DK, Dalekos GN, Merkoulopoulos MH et al. Cryoglobulinaemia due to chronic viral hepatitis infections is not a major problem in clinical practice. Eur J Intern Med 2001; 12:435-41.
16. Frangeul L, Musset L, Cresta P, Cacoub P, Huraux J-M, Lunel F. Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinaemia. J Hepatol 1996; 25:427-32.
17. Bouvier-Alias M, Patel K, Dahari H et al. Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication. Hepatology 2002; 36:211-8.
18. Soffredini R, Rumi MG, Parravicini ML et al. Serum levels of hepatitis C core antigen as marker of infection and response to therapy. Am J Gastroenterol 2004; 99:1738-43.
19. Choo S-H, So H-S, Cho JM, Ryu WS. Association of hepatitis C virus particles with immunoglobulin: a mechanism for persistent infection. J Gen Virol 1995; 76:2337-41.
20. Aiyama T, Yoshioka K, Okumura A et al. Hypervariable region sequence in cryoglobulin-associated hepatitis C virus in sera of patients with chronic hepatitis C: relationship to antibody response against hypervariable region genome. Hepatology 1996; 24:1340-50.
21. Hijikata M, Shimizu YK, Kato H et al. Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes. J Virol 1993; 67:1953-8.
22. Valcavi P, Medici MC, Casula F et al. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals. J Med Virol 2004; 73:397-403.
23. Ward KN, Dhaliwal W, Ashworth KL, Clutterbuck EJ, Teo CG. Measurement of antibody avidity for hepatitis C virus distinguishes primary antibody responses from passively acquired antibody. J Med Virol 1994; 43:367-72.
24. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinaemia. N Engl J Med 1992; 327:1490-5.
25. Dammacco F, Sansonno D. Antibodies to hepatitis C virus in essential mixed cryoglobulinaemia. Clin Exp Immunol 1992; 87:352-6.
26. L'Abbate A, Cutrupi S, Rognetta M, Fabiano C, Craxi A. IgM and IgG antibodies to hepatitis C virus in patients with mixed cryoglobulinaemia. Clin Exp Immunol 1993; 94:313-6.